森鹰窗业 reported revenue of ¥0.22B for the period ended 2026-06-30, -9.9% year on year. Net income was ¥-0.04B, a -17.4% net margin on a 13.5% gross margin. The largest revenue line is 节能铝包木窗 at 58% of the total. Free cash flow for the period was ¥0.00B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.22B | -9.9% |
| Gross profit | ¥0.03B | — |
| Operating income | ¥-0.04B | — |
| Net income | ¥-0.04B | — |
| Gross margin | 13.5% | Net margin -17.4% |
| Revenue Q/Q | +112.1% | — |
| Segment | Revenue | Share |
|---|---|---|
| 节能铝包木窗 | ¥0.13B | 58.4% |
| 铝合金窗 | ¥0.07B | 33.2% |
| 幕墙及阳光房 | ¥0.01B | 4.7% |
| 其他(补充) | ¥0.01B | 3.1% |
| 新塑窗 | ¥0.00B | 0.6% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.19B | 86.5% |
| R&D | ¥0.02B | 6.8% |
| SG&A | ¥0.06B | 25.9% |
| Tax & other | ¥0.00B | 0.1% |
| Item | Amount |
|---|---|
| Total assets | ¥2.14B |
| Total liabilities | ¥0.55B |
| Shareholders' equity | ¥1.59B |
| Equity / assets | 74.3% |
| Operating cash flow | ¥0.01B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥0.00B |
| Cash conversion (OCF / net income) | -19% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
实朴检测 ・ 纽泰格 ・ 泓博医药 ・ 荣信文化 ・ 飞沃科技 ・ 盛帮股份 ・ 五洲医疗 ・ 华康洁净 ・ 和顺科技 ・ 瑞泰新材 ・ 普瑞眼科 ・ 宏源药业
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies